SHSE:600222 (China)
Â
Class A
Â¥
5.41
+0.060 (+1.12%)
Mar 27
What is a stock summary page? Click here for an overview.
Business Description
Henan Taloph Pharmaceutical Stock Co Ltd
NAICS : 325411
SIC : 2834
ISIN : CNE0000010L8
Share Class Description:
SHSE:600222: Class ACompare
Compare
Traded in other countries / regions
600222.China Index Membership
SSE Composite Index IPO Date
1999-11-05Description
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.43 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.59 | |||||
| Debt-to-EBITDA | 10.04 | |||||
| Interest Coverage | 41 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.62 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.4 | |||||
| 3-Year EBITDA Growth Rate | -8.6 | |||||
| 3-Year EPS without NRI Growth Rate | 33.6 | |||||
| 3-Year Book Growth Rate | 2.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.48 | |||||
| 9-Day RSI | 54.97 | |||||
| 14-Day RSI | 53.5 | |||||
| 3-1 Month Momentum % | 4.19 | |||||
| 6-1 Month Momentum % | 12.09 | |||||
| 12-1 Month Momentum % | 5.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 0.81 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 123.1 | |||||
| Days Sales Outstanding | 143.55 | |||||
| Days Payable | 119.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.52 | |||||
| Dividend Payout Ratio | 0.13 | |||||
| Forward Dividend Yield % | 0.52 | |||||
| 5-Year Yield-on-Cost % | 0.53 | |||||
| Shareholder Yield % | -4.43 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.2 | |||||
| Operating Margin % | 6.91 | |||||
| Net Margin % | 4.54 | |||||
| FCF Margin % | -1.18 | |||||
| ROE % | 5.78 | |||||
| ROA % | 2.5 | |||||
| ROIC % | 6.34 | |||||
| 3-Year ROIIC % | -0.73 | |||||
| ROC (Joel Greenblatt) % | 11.74 | |||||
| ROCE % | 5.16 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.03 | |||||
| PE Ratio without NRI | 38.1 | |||||
| Price-to-Owner-Earnings | 66 | |||||
| PS Ratio | 1.54 | |||||
| PB Ratio | 1.97 | |||||
| Price-to-Tangible-Book | 2.58 | |||||
| EV-to-EBIT | 39.73 | |||||
| EV-to-EBITDA | 39.73 | |||||
| EV-to-Revenue | 1.85 | |||||
| EV-to-FCF | -156.22 | |||||
| Price-to-GF-Value | 0.85 | |||||
| Price-to-Projected-FCF | 3.4 | |||||
| Price-to-Median-PS-Value | 0.66 | |||||
| Price-to-Graham-Number | 2.09 | |||||
| Earnings Yield (Greenblatt) % | 2.52 | |||||
| FCF Yield % | -0.75 | |||||
| Forward Rate of Return (Yacktman) % | -6.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Henan Taloph Pharmaceutical Stock Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,967.713 | ||
| EPS (TTM) (Â¥) | 0.159 | ||
| Beta | 1.35 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 27.11 | ||
| 14-Day RSI | 53.5 | ||
| 14-Day ATR (Â¥) | 0.15558 | ||
| 20-Day SMA (Â¥) | 5.343 | ||
| 12-1 Month Momentum % | 5.19 | ||
| 52-Week Range (Â¥) | 4.03 - 5.87 | ||
| Shares Outstanding (Mil) | 573.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Henan Taloph Pharmaceutical Stock Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Henan Taloph Pharmaceutical Stock Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Henan Taloph Pharmaceutical Stock Co Ltd Frequently Asked Questions
What is Henan Taloph Pharmaceutical Stock Co Ltd(SHSE:600222)'s stock price today?
The current price of SHSE:600222 is ¥5.41. The 52 week high of SHSE:600222 is ¥5.87 and 52 week low is ¥4.03.
When is next earnings date of Henan Taloph Pharmaceutical Stock Co Ltd(SHSE:600222)?
The next earnings date of Henan Taloph Pharmaceutical Stock Co Ltd(SHSE:600222) is .
Does Henan Taloph Pharmaceutical Stock Co Ltd(SHSE:600222) pay dividends? If so, how much?
The Dividend Yield %  of Henan Taloph Pharmaceutical Stock Co Ltd(SHSE:600222) is 0.52% (As of Today), Highest Dividend Payout Ratio of Henan Taloph Pharmaceutical Stock Co Ltd(SHSE:600222) was 1.43. The lowest was 0.13. And the median was 0.4. The  Forward Dividend Yield % of Henan Taloph Pharmaceutical Stock Co Ltd(SHSE:600222) is 0.52%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers